SearchInput the word you want to find
- ABOUT JSMO
- HOME
- ABOUT JSMO
- 2022 Award Recipients
2022 Award Recipients
2022 Award Recipients
| Annals of Oncology Award | ||
|---|---|---|
| Name | Affiliation | Awarded Paper |
| Chigusa Morizane | Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital |
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial https://www.sciencedirect.com/science/article/pii/S0923753420325576 |
| Young Investigator Award | ||
| Name | Affiliation | Title |
| Masayuki Shirasawa | Department of Thoracic Oncology, National Cancer Center Hospital |
Differential immune-related microenvironment determines PD-1/PD-L1 blockade efficacy in patients with advanced NSCLC |
| Akiko Tateishi | Department of Thoracic Oncology, National Cancer Center Hospital |
Prognosis and efficacy of adjuvant therapy in post-surgical NSCLC patients with WES-based genetic profiling |
| Yosuke Tanaka | Division of Cellular Signaling, National Cancer Center Research Institute |
Discovery of actionable vulnerabilities in scirrhous-type gastric cancer |
| Tsuyoshi Harada | Department of Rehabilitation, National Cancer Center Hospital East |
Prognostic impacts of loss of skeletal muscle mass during neoadjuvant chemotherapy in older esophageal cancer patients |
| Yohei Harada | Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University |
A Prospective Study of Biomarkers and Risk Scores for predicting Venous Thromboembolism in Patients with Advanced Cancer |
| Yuki Matsubara | Department of Clinical Oncology, Aichi Cancer Center Hospital |
Ramucirumab-containing chemotherapy for gastrointestinal neuroendocrine carcinoma: RAM-NEC study (WJOG13420G) |
| Mori Keiichiro | Department of Urology, The Jikei University School of Medicine |
Prognostic role of Vascular Endothelial Growth Factor and Vascular Cell Adhesion Molecule-1 in bladder carcinoma |
| Tatsuya Yokoyama | Kushiro Rosai Hospital | HGCSG1902: Multicenter, prospective, observational study for patients with dysgeusia caused by chemotherapy. |
| Mark M. Ando | Division of Medical Oncology, University of the Philippines – Philippine General Hospital |
Use of virtual reality for management of anxiety and depression among chemotherapy-naive Filipino breast cancer patients |
| Ryan Ying Cong Tan | Division of Medical Oncology, National Cancer Centre Singapore, Singapore |
HER2 expression and survival outcomes in HER2-low early breast cancer: retrospective multicenter cohort analysis |
| Yue Wang | The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School |
FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma |
| Yung-Yeh Su | National Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan |
Potential Roles of Gut Microbiome in Patients with Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors |
※Titles omitted, listed in Japanese alphabetical order.
※Affiliations are listed as of the time of the award.
Scenes from the Award Ceremony
※Click to view a larger image.
©Japanese Society of Medical Oncology All rights reserved.